Lisa T. Dooley

7.8k citations
15 papers · 6.1k indexed · 5 hit papers · h-index 14
Topics
Psoriasis: Treatment and Pathogenesis (13 papers)Dermatology and Skin Diseases (10 papers)Autoimmune and Inflammatory Disorders Research (4 papers)

In The Last Decade

Lisa T. Dooley

15 papers receiving 5.9k citations

Hit Papers

Efficacy and safety of ustekinumab, a human interleukin-1...2005202620122019200820082005201020074008001.2k

Peers

Lisa T. Dooley
Comparison fields: 5 of 91
  • Immunology 5.4k
  • Dermatology 2.9k
  • Rheumatology 1.3k
  • Pathology and Forensic Medicine 969
  • Hematology 873
Replace Newman Yeilding with:
Newman Yeilding United States
Shu Li United States
Yasmine Wasfi United States
Yaung‐Kaung Shen United States
B. Randazzo United States
Howard Sofen United States
Michael Song United States
Bernard S. Goffe United States
Robert Matheson United States
Marieke M.B. Seyger Netherlands
Lisa T. Dooley relative to Newman Yeilding United States Newman Yeilding's profile →
Citations per field
00.5×1.5×
Newman Yeilding · 1×
Citations per year

Countries citing papers authored by Lisa T. Dooley

Since Specialization
Citations

This map shows the geographic impact of Lisa T. Dooley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa T. Dooley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa T. Dooley more than expected).

Fields of papers citing papers by Lisa T. Dooley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa T. Dooley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa T. Dooley. The network helps show where Lisa T. Dooley may publish in the future.

Co-authorship network of co-authors of Lisa T. Dooley

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa T. Dooley. A scholar is included among the top collaborators of Lisa T. Dooley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa T. Dooley. Lisa T. Dooley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasisbreakdown →
644
2 76
3
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)breakdown →
1067
4
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)breakdown →
1434
5 26
6
Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.
2
7 140
8
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasisbreakdown →
588
9 116
10 423
11
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialbreakdown →
838
12 456
13 126
14 115
15
The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
68

About Lisa T. Dooley

Lisa T. Dooley is a scholar working on Dermatology, Immunology and Hematology, having authored 15 papers that have together received 6.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (10 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). The work is most often cited by research in Dermatology (2.9k citations), Immunology (5.4k citations) and Rheumatology (1.3k citations). Lisa T. Dooley has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Cynthia Guzzo, Shu Li, Kim Papp, Newman Yeilding, Craig L. Leonardi, Robert J. Evans, Kristian Reich, Gerald G. Krueger, Mark Lebwohl and Richard G. Langley. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026